Literature DB >> 15377545

Serum paraoxonase activity is decreased in the active stage of Behçet's disease.

S Karakucuk1, G Baskol, A O Oner, M Baskol, E Mirza, M Ustdal.   

Abstract

AIMS: To evaluate paraoxonase1 (PON1) activities and malondialdehyde (MDA) levels, one of the end products of lipid peroxidation induced by reactive oxygen species in patients with Behçet's disease (BD) in the active stage.
METHODS: Serum MDA levels and PON1 levels were measured spectrophotometrically in 16 patients with BD in the active stage of the disease and in 15 healthy subjects who constituted the control group.
RESULTS: In the BD group, median (range) serum PON1 and MDA levels were 149.64 U/l (88.02-281.68) and 1.21 nmol/ml (0.90-3.42), respectively. In the control group, median (range) serum PON1 and MDA levels were 206.86 U/l (114.43-422.52) and 0.72 nmol/ml (0.50-1.12), respectively. There was a statistically significant decrease in serum PON1 levels (p = 0.02) and an increase in serum MDA levels (p<0.001) in patients with BD in the active stage when compared to controls.
CONCLUSION: Endothelial damage and increased polymorph nuclear leucocyte activity in the active stage of BD could result in a pro-oxidation environment which, in turn, results in decreased antioxidant PON activity and increased lipid peroxidation as evidenced by increased MDA levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377545      PMCID: PMC1772352          DOI: 10.1136/bjo.2004.043398

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

Review 1.  Paraoxonase and atherosclerosis.

Authors:  P N Durrington; B Mackness; M I Mackness
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

Review 2.  Free radicals in disease processes: a compilation of cause and consequence.

Authors:  J M Gutteridge
Journal:  Free Radic Res Commun       Date:  1993

Review 3.  Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

Authors:  B Halliwell
Journal:  Lancet       Date:  1994-09-10       Impact factor: 79.321

Review 4.  Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins.

Authors:  M I Mackness; B Mackness; P N Durrington; P W Connelly; R A Hegele
Journal:  Curr Opin Lipidol       Date:  1996-04       Impact factor: 4.776

5.  Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.

Authors:  M Aviram; M Rosenblat; S Billecke; J Erogul; R Sorenson; C L Bisgaier; R S Newton; B La Du
Journal:  Free Radic Biol Med       Date:  1999-04       Impact factor: 7.376

6.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  Serum oxidant/antioxidant status in patients with Behçet's disease.

Authors:  Seyithan Taysi; Ibrahim Kocer; Ramazan Memisogullari; Ahmet Kiziltunc
Journal:  Ann Clin Lab Sci       Date:  2002       Impact factor: 1.256

8.  Relationship between lipid peroxidation and disease activity in patients with Behçet's disease.

Authors:  A Orem; H Efe; O Değer; G Cimşit; H A Uydu; B Vanizor
Journal:  J Dermatol Sci       Date:  1997-11       Impact factor: 4.563

Review 9.  Human serum paraoxonase.

Authors:  B Mackness; P N Durrington; M I Mackness
Journal:  Gen Pharmacol       Date:  1998-09

10.  Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease.

Authors:  A Orem; O Değer; O Memiş; S Bahadir; E Ovali; G Cimşit
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

View more
  13 in total

1.  Serum paraoxonase, arylesterase activity, and oxidative status in patients with nasal polyp.

Authors:  Wenwei Hao; Yongping Zhu; Li Meng; Changbao Ni; Jing Yang; Huifang Zhou
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-13       Impact factor: 2.503

2.  Serum paraoxonase and arylesterase activities in patients with chronic otitis media.

Authors:  Mahfuz Turan; Rıfkı Ucler; Mehmet Aslan; Ferhat Kalkan; Abdullah Taskın; Mehmet Fatih Garca; Hakan Cankaya
Journal:  Redox Rep       Date:  2015-05-13       Impact factor: 4.412

3.  Oxidative stress in chronic otitis media.

Authors:  Elif Baysal; Nurten Aksoy; Ferit Kara; Seyithan Taysi; Abdullah Taşkın; Hasan Bilinç; Cengiz Cevik; Fatih Celenk; Muzaffer Kanlıkama
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-19       Impact factor: 2.503

4.  Serum paraoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis.

Authors:  Ramazan Esen; Mehmet Aslan; Mehmet Emin Kucukoglu; Aytekin Cıkman; Umit Yakan; Mahmut Sunnetcioglu; Sahbettin Selek
Journal:  Wien Klin Wochenschr       Date:  2015-02-24       Impact factor: 1.704

5.  Reduced serum paraoxonase-1 levels in vitiligo: further evidence of oxidative stress.

Authors:  Yavuz Yesilova; Enver Turan; Derya Ucmak; Sahabettin Selek; İbrahim Halil Yavuz; Osman Tanrıkulu
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

6.  Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients.

Authors:  Fazile Hatipoglu Erdem; Saliha Karatay; Kadir Yildirim; Ahmet Kiziltunc
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

7.  Assessment of serum homocysteine, endothelin-1, and nitric oxide levels in behçet's disease.

Authors:  Abeer A Hodeib; Tarek A Elsharawy; Hisham A Fawzi
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

8.  Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1.

Authors:  David A Stoltz; Egon A Ozer; Peter J Taft; Marilyn Barry; Lei Liu; Peter J Kiss; Thomas O Moninger; Matthew R Parsek; Joseph Zabner
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

9.  Serum paraoxonase undergoes inhibition and proteolysis during experimental acute pancreatitis.

Authors:  Neus Franco-Pons; Judit Marsillach; Jorge Joven; Jordi Camps; Daniel Closa
Journal:  J Gastrointest Surg       Date:  2008-03-11       Impact factor: 3.452

10.  Serum oxidative-antioxidative status in patients with ankylosing spondilitis.

Authors:  Mehmet Karakoc; Ozlem Altindag; Huseyin Keles; Neslihan Soran; Sahabettin Selek
Journal:  Rheumatol Int       Date:  2007-04-19       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.